Imazalil
More information about Imazalil
| Cancer: |
Currently listed
|
|---|
Chemical Listing Details
| Listed for: |
Cancer
|
|---|---|
| Date of Listing: |
05/20/2011
|
| Basis for Listing: |
Authoritative Bodies-US Environmental Protection Agency
|
| Cancer | |
| No Significant Risk Level (NSRL): |
11 µg/day
|
|---|
| Cancer: |
|---|
Public Notices Related to this Chemical
- Original Proposed Amendment to Section 25705 Specific Regulatory Levels Posing No Significant Risk: Imazalil
- Amendment to Section 25705 Specific Regulatory Levels Posing No Significant Risk: Imazalil
- Proposed Amendment To Section 25705 Specific Regulatory Levels Posing No Significant Risk: Imazalil
- Notice of Withdrawal and Resubmittal of Proposed Rulemaking Amendment to Section 25705 Specific Regulatory Levels Posing No Significant Risk: Imazalil
- Chemicals Listed Effective May 20, 2011 As Known To The State Of California To Cause Cancer: Imazalil
- Candidates for Listing via the Authoritative Bodies Mechanism Found Not to Meet the Regulatory Criteria for Reproductive Toxicity: Thiabendazole (CAS No. 148-79-8) Thiabendazole hypophosphate salt (CAS No. 28558-32-9) Imazalil (CAS No. 35554-44-0)
- Notice of Intent to List Imazalil
- Imazalil Under Consideration for Possible Listing Via the Authoritative Bodies Mechanism: Request for Relevant Information
- Retraction of Notice of Intent to List for Imazalil, a Candidate for Listing via the Authoritative Bodies Mechanism
- Notice of Intent to List: Avermectin B1, Delta isomer of avermectin B1, N-Methylpyrrolidone, and Imazalil
- Chemicals Meeting the Critieria for Listing as Developmental and Reproductive Toxicants (DARTs) Via the Authoritative Bodies Mechanism: 4 Chemicals Identified By U.S. EPA